Large (>3.8 cm) clear cell renal cell carcinomas are morphologically and immunohistochemically heterogeneous
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Large (>3.8 cm) clear cell renal cell carcinomas are morphologically and immunohistochemically heterogeneous
Authors
Keywords
Clear cell renal cell carcinoma, Intratumour heterogeneity, Tumour size, Fuhrman’s grade, Immunohistochemistry
Journal
VIRCHOWS ARCHIV
Volume 466, Issue 1, Pages 61-66
Publisher
Springer Nature
Online
2014-11-04
DOI
10.1007/s00428-014-1673-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- COX-2 as a target for cancer chemotherapy
- (2014) Nilanjan Ghosh et al. Pharmacological Reports
- Cell heterogeneity in clear cell renal cell carcinoma
- (2013) José I. Lopez et al. APMIS
- Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-up
- (2013) Ben Y. Zhang et al. BJU INTERNATIONAL
- Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts
- (2013) X Wang et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells
- (2013) Tania Fiaschi et al. CELL CYCLE
- Implications of intratumour heterogeneity for treatment stratification
- (2013) Andrew Crockford et al. JOURNAL OF PATHOLOGY
- Renal tumors with clear cells. A review
- (2013) José I. López PATHOLOGY RESEARCH AND PRACTICE
- Attractor Metabolic Networks
- (2013) Ildefonso M. De la Fuente et al. PLoS One
- Incidencia, prevalencia y mortalidad del cáncer renal en España: estimaciones y proyecciones para el período 1998-2022
- (2012) D.L.B. Souza et al. Actas Urologicas Espanolas
- Renal Cell Neoplasms Contain Shared Tumor Type–Specific Copy Number Variations
- (2012) John M. Krill-Burger et al. AMERICAN JOURNAL OF PATHOLOGY
- Proteomics and the search for biomarkers for renal cancer
- (2012) Rachel A. Craven et al. CLINICAL BIOCHEMISTRY
- Targeted exome sequencing in clear cell renal cell carcinoma tumors suggests aberrant chromatin regulation as a crucial step in ccRCC development
- (2012) Gerben Duns et al. HUMAN MUTATION
- BAP1 loss defines a new class of renal cell carcinoma
- (2012) Samuel Peña-Llopis et al. NATURE GENETICS
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biomarker für Nierenkarzinome
- (2012) H. Moch PATHOLOGE
- Tumours associated with BAP1 mutations
- (2012) Rajmohan Murali et al. PATHOLOGY
- Heterogeneity and Tumor History
- (2012) D. Shibata SCIENCE
- Adult renal cell carcinoma with rhabdoid morphology represents a neoplastic dedifferentiation analogous to sarcomatoid carcinoma
- (2011) Jennifer R. Chapman-Fredricks et al. Annals of Diagnostic Pathology
- Handling and reporting of nephrectomy specimens for adult renal tumours: a survey by the European Network of Uropathology
- (2011) Ferran Algaba et al. JOURNAL OF CLINICAL PATHOLOGY
- Future medical applications of single-cell sequencing in cancer
- (2011) Nicholas Navin et al. Genome Medicine
- Carbonic Anhydrase IX in Renal Cell Carcinoma: Implications for Prognosis, Diagnosis, and Therapy
- (2010) Alexander B. Stillebroer et al. EUROPEAN UROLOGY
- Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma
- (2008) Maria F. Serrano et al. CANCER
- Diagnostic and Prognostic Molecular Markers in Renal Cell Carcinoma
- (2008) Hari S.G.R. Tunuguntla et al. JOURNAL OF UROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started